Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Clinical Pharmacokinetics|June 22, 2005
Pharmacokinetics of hydroxyethyl starchCornelius Jungheinrich, Thomas A NeffDrugs in R&D|January 17, 2004
Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery : a randomised, double-blind studyCornelius Jungheinrich, Wilhelm Sauermann, Frank Bepperling, et al.Anesthesia and Analgesia|August 29, 2002
The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairmentCornelius Jungheinrich, Roland Scharpf, Manfred Wargenau, et al.Anesthesia and Analgesia|July 18, 2008
The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trialsSibylle A Kozek-Langenecker, Cornelius Jungheinrich, Wilhelm Sauermann, et al.Anesthesia and Analgesia|April 23, 2003
Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injuryThomas A Neff, Martin Doelberg, Cornelius Jungheinrich, et al.Journal of Cardiothoracic and Vascular Anesthesia|February 25, 2011
Efficacy and safety of hydroxyethyl starch 6% 130/0.4 in a balanced electrolyte solution (Volulyte) during cardiac surgeryEva M Base, Thomas Standl, Andrea Lassnigg, et al.Anesthesiology|May 26, 2007
Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarchSweeta D Gandhi, Richard B Weiskopf, Cornelius Jungheinrich, et al.European Journal of Anaesthesiology|October 24, 2025
Safety and efficacy of 6% hydroxyethyl starch in patients undergoing major surgery: The randomised controlled PHOENICS trialWolfgang Buhre, Óscar Díaz-Cambronero, Simon Schaefer, et al.Pageof 1